PDCD1 and neoplasm: Considering that MC38-OVA is sensitive to the PD-1 immune checkpoint inhibitor, cohorts of tumor-bearing mice were also injected with anti-PD-1 or with isotype control antibodies to serve as positive and negative controls, respectively (Fig. 8, C and D).